Clinical trial
Clinical Validation of Continuous Glucose Monitoring in Glycemic Management of Critically Ill Sepsis Patients: A Prospective Randomized Clinical Study
NCT07686939 is registered in ClinicalTrials.gov with Taizhou Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Validation of Continuous Glucose Monitoring in Glycemic Management of Critically Ill Sepsis Patients: A Prospective Randomized Clinical Study
- Lead sponsor
- Taizhou Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2023
- Completion date
- December 31, 2025
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
glycemic control, hyperglycemia, sepsis